121. Targeted Gene Therapy in the Treatment of X-Linked Hyper IgM Syndrome

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33726-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Case Report of X-Linked Hyper-IgM Syndrome With Acquired Toxoplasmic Encephalitis

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2017English

325. Targeted Gene Addition Strategies for the Treatment of X-Linked Lymphoproliferative Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

Hyper IgM Syndrome: Two Mutations Distinguish HIM.

Journal of Clinical Investigation
Medicine
1994English

Lymphoid Abnormalities in CD40 Ligand Transgenic Mice Suggest the Need for Tight Regulation in Gene Therapy Approaches to Hyper Immunoglobulin M (IgM) Syndrome

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2000English

Gene Therapy for X-Linked Chronic Granulomatous Disease (Net4CGD)

Human gene therapy. Clinical development
Genetics
2015English

Correction:Occurrence of Leukaemia Following Gene Therapy of X-Linked SCID

Nature Reviews Cancer
Cancer ResearchOncology
2003English

Hyper IgM Syndrome Associated With Defective CD40-mediated B Cell Activation.

Journal of Clinical Investigation
Medicine
1994English

Targeted Disruption of Dkc1, the Gene Mutated in X-Linked Dyskeratosis Congenita, Causes Embryonic Lethality in Mice

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatosis

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy